olaparib beva maintenance in newly diagnosed, advanced ovarian cancer (oc) treated with pch bev
Published 4 years ago • 115 plays • Length 10:01Download video MP4
Download video MP3
Similar videos
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
13:27
solo1: maintenance olaparib following platinum-based ct in ovarian cancer & brcam
-
9:49
paola-1 phase 3 data: olaparib plus bevacizumab maintenance for advanced ovarian cancer
-
3:37
selecting patients to be treated with maintenance olaparib in the paola-1 trial
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib
-
6:56
#esmo19: positive trial for ovarian cancer: paola-1/engot-ov25
-
3:56
solo1 trial of maintenance olaparib in advanced ovarian cancer | susana banerjee
-
9:36
maintenance olaparib following platinum-based chemotherapy for newly diagnosed ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
1:04
olaparib maintenance therapy in ovarian cancer
-
3:28
implications of paola-1 in advanced ovarian cancer
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
7:56
maintenance therapy in ovarian cancer
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer